CYPHERPUNK TECHNOLOGIES INC. Increase in Carrying Amount of Redeemable Preferred Stock
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Increase in Carrying Amount of Redeemable Preferred Stock of $244.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-04-01.
Discontinued › Shareholders' Equity
us-gaap:IncreaseInCarryingAmountOfRedeemablePreferredStock · last filed 2019-04-01
- CYPHERPUNK TECHNOLOGIES INC. increase in carrying amount of redeemable preferred stock for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. increase in carrying amount of redeemable preferred stock for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. increase in carrying amount of redeemable preferred stock for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. increase in carrying amount of redeemable preferred stock for the quarter ending 2017-03-31 was $244.00K, a 78.29% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. increase in carrying amount of redeemable preferred stock for fiscal 2017 was $244.00K, a 94.75% decline from fiscal 2016.
- CYPHERPUNK TECHNOLOGIES INC. increase in carrying amount of redeemable preferred stock for fiscal 2016 was $4.65M.
| Period end | Increase in Carrying Amount of Redeemable Preferred Stock 3 month | Increase in Carrying Amount of Redeemable Preferred Stock 6 month | Increase in Carrying Amount of Redeemable Preferred Stock 9 month | Increase in Carrying Amount of Redeemable Preferred Stock 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $0.00 derived: sum of 2 quarters · filed 2019-04-01 | $0.00 derived: sum of 3 quarters · filed 2019-04-01 | $244.00K 10-K · filed 2019-04-01 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | $244.00K 10-Q · filed 2018-11-09 | $1.41M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-08 | $244.00K 10-Q · filed 2018-08-08 | $1.41M derived: sum of 3 quarters · filed 2018-08-08 | $2.60M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | $244.00K 10-Q/A · filed 2018-08-08 | $1.41M derived: sum of 2 quarters · filed 2018-08-08 | $2.60M derived: sum of 3 quarters · filed 2018-08-08 | $3.77M derived: sum of 4 quarters · filed 2018-08-08 |
| 2016-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $2.35M derived: sum of 2 quarters · filed 2018-02-23 | $3.53M derived: sum of 3 quarters · filed 2018-02-23 | $4.65M 10-K · filed 2018-02-23 |
| 2016-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $2.36M derived: sum of 2 quarters · filed 2017-11-13 | $3.48M 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $2.30M 10-Q · filed 2017-08-11 | ||
| 2016-03-31 | $1.12M 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |